Contact:

Brenna Garay
Manager, Marketing Communications
267.569.2432
brenna.garay@mtiadvantage.com

 

Press Releases


MTI RANKED NO. 10 BY
DELOITTE FAST 50 PROGRAM

Company Recognized for Five-Year
Sales Growth of 719%

LANGHORNE, PA (November 6, 2008) – Deloitte, LLP has
ranked MTI, the pioneer of communication optimization to
healthcare providers, No. 10 among the 50 fastest-growing
technology and life sciences companies in Greater Philadelphia. 
This distinguished ranking is credited to the company’s 5-year revenue growth of 719%, from 2003 through 2007.

“This is the third growth-related award we’ve received this year…
and our first time in the top 10. We were recently acknowledged
as members of Inc. 5000 and the Philly 100, and have previously been acknowledged as one of the Best Places to Work in Pennsylvania,” said MTI President and CEO, Bill Clapper.  “Our
growth rate is a testament to our alignment with the pharmaceutical marketplace, the value we deliver to our clients and our ability to execute in a very complex industry. Our core product, ExtenderTM, engages healthcare providers in a ‘dialogue’ about a specific pharmaceutical brand based on the provider’s individual channel
and message preferences.  This approach increases receptivity so
that providers are more likely to have received the information necessary to make critical prescribing decisions for their patients.
The need to create this communication bond without the use of a
sales rep. is a challenge facing most pharmaceutical brand teams today – a challenge for which we provide a unique answer.”

The core technology behind Extender leverages many of the same selling strategies as a traditional sales representative. It personally engages healthcare providers, 1-to-1, while using every interaction
to learn more about, and act on, the provider’s personal channel and message preferences. Extender tracks each provider’s prescribing response to prior contact and employs MTI’s proprietary technology
to dynamically determine the next appropriate communication. Additionally, Extender efficiently administers provider requests for product samples and educational materials. With Extender, the vital relationship between the brand and the prescriber can comprehen-sively be managed at a much lower cost than that of a sales representative.

“Deloitte’s Greater Philadelphia Fast 50 companies have shown the strength, vision and tenacity to succeed in today’s very competitive technology environment,” said Michael J. Purcell, Greater Philadelphia Marketplace Technology, Media, and Telecommunications Leader, Deloitte & Touche, LLP.  “We applaud the success of MTI and acknowledge it as one of the very few to accomplish such a fast growth rate over the past five years.”

_____________________

The Greater Philadelphia Fast 50 program is presented by Deloitte
and sponsored by Fragomen, Del Rey, Bernsen & Loewy, LLP, The Judge Group, and UK Trade & Investment.

To qualify for the Fast 50, companies must have had operating revenues of at least $50,000 in 2003 and $5,000,000 in 2007, be headquartered in North America, and be a company that owns proprietary technology or proprietary intellectual property that contributes to a significant portion of the company’s operating revenues; or devotes a significant proportion of revenues to the research and development of technology.  Using other companies’ technology or intellectual property in a unique way does not qualify.

Winners of the regional Fast 50 programs in the United States and Canada are automatically entered in Deloitte’s Fast 500 program, which ranks North America’s top 500 fastest growing technology, media, telecommunication, and life sciences companies.  For more information on Deloitte’s Fast 50 or Fast 500 programs, visit www.fast500.com.

###

About MTI
MTI is the pioneer of pharmaceutical marketing products designed to optimize communication to healthcare providers and increase revenue for pharmaceutical brands. Our products connect brands with physicians, 1-to-1, based on individual communication preferences – building bonds that deliver the greatest impact on prescribing. Additional information can be accessed at www.mtiadvantage.com, via email at info@mtiadvantage.com or by calling 267.569.2400.

About Deloitte
Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, and its network of member firms, each of which is a legally separate and independent entity.  Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu and its members firms.  Please see wwww.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.